BIOTECHNOLOGY overview

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, AB / ACCESSWIRE / April 17, 2024 / Asia Green Biotechnology Corp. (" Asia Green " or the " Company ") (CSE:ASIA) announces that it is unlikely to meet the filing date of April 29, 2024 (" Filing Date "), as required under National Instrument 51-102, for filing of the following continuous disclosure documents (collectively, the " Documents "): The Company's Annual Audited Financial Statements for the year...

CALGARY, AB / ACCESSWIRE / April 12, 2024 / Asia Green Biotechnology Corp. ("AGB" or the "Company") (CSE:ASIA), announced today that it has changed its auditor from Paul J. Rozek Professional Corporation, Chartered Professional Accountant (the "Former Auditor") to MNP LLP (the "Successor Auditor"), effective April 5, 2024 (the "Effective Date"). At the request of the Company, the Former Auditor resigned as the auditor of the Company and the Board of Directors of the Company appointed the...

EQS-Media / 08.04.2024 / 11:58 CET/CEST Anbio Biotechnology is expanding into the European market with its star product AF-100 C, a ground-breaking compact fluorescent immunoassay analyzer, which is to revolutionize point-of-care testing. With over 70 assays, the AF-100 C aims to empower healthcare providers in the EU, enhancing patient care and prognosis. Frankfurt, Germany – In a strategic move to broaden its presence in the European Union, Anbio Biotechnology (Anbio), a global leader in...

Jamie Metzl, one of the world's leading technology and healthcare futurists, is all set to headline at the Global AI Show, taking place at the Grand Hyatt Dubai on April 16 and 17, 2024. DUBAI, Mar 25, 2024 - (ACN Newswire) - The Global AI Show is thrilled to announce Jamie Metzl, esteemed author, technology visionary, and healthcare futurist, as a featured speaker for its upcoming two-day conference. Set to convene thought leaders and industry experts from across the globe, this event promises...

HONG KONG, Mar 18, 2024 - (ACN Newswire) - Essex Bio-Technology Limited ("Essex" or the "Group", Stock Code: 1061.HK) today announced the annual results for the year ended 31 December 2023. Financial Performance The Group weathered the headwinds and managed to deliver sound performances amidst the challenging trading environment in 2023. During the year under review, the Group achieved a consolidated revenue of approximately HK$1,706.6 million, with an increase of 29.5% as compared to last year,...

CYBER ENVIRO-TECH, INC ACQUIRES STABLEX AND SECURES EXCLUSIVE GLOBAL LICENSES TO INTELLECTUAL PROPERTY RIGHTS FROM KAM BIOTECHNOLOGY LTD. PR Newswire SCOTTSDALE, Ariz., Feb. 27, 2024 SCOTTSDALE, Ariz. , Feb. 27, 2024 /PRNewswire/ -- (OTC Pink: CETI), Cyber Enviro-Tech, Inc. is pleased to announce the acquisition of the patent for Stablex and the geographic expansion of its license rights for seven proprietary intellectual biotechnology compounds of KAM Biotechnology Ltd ("KAM") from the United...

CALGARY, AB / ACCESSWIRE / February 21, 2024 / ASIA GREEN BIOTECHNOLOGY CORP. (CSE:ASIA) (" Asia Green " or the " Company ") is pleased to announce that it has entered into a non-binding letter of intent (" LOI ") to acquire all of the issued and outstanding shares of Burton Growers Ltd. (" Burton Growers ") and Green Sight Agri-Holdings Inc. (" Green Sight "), two private companies active in the Canadian hemp production industry. Burton Growers is the owner of a 25,000 sq. ft. greenhouse and...

Nuvalent to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference PR Newswire CAMBRIDGE, Mass., Feb. 1, 2024 CAMBRIDGE, Mass. , Feb. 1, 2024 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter , Ph.D., Chief Executive Officer, and Alexandra Balcom , Chief Financial Officer, will participate in a...